Literature DB >> 3905472

Immunocytochemical localization of insulin-immunoreactive cells in the pancreatic ducts of rats treated with trypsin inhibitor.

C V Weaver, R L Sorenson, H C Kaung.   

Abstract

It is well known that soybean trypsin inhibitor exerts trophic effects on the exocrine pancreas, resulting in the hypertrophy of acinar cells. Some evidence also exists for hyperplasia in acinar tissue, the ductal epithelium and islet tissue. Rats maintained for 3 weeks on an oral administration of soybean trypsin inhibitor (200 mg/50 ml drinking water) were compared with untreated animals. Significant changes were noted in treated animals (p less than 0.01). Trypsin inhibitor-treated rats showed an increase in pancreatic weight (2.33 +/- 0.46 g). The volume ratio of acinar, islet and connective tissue as measured by the stereology point-count technique remained the same in both groups. Ductal tissue, however, exhibited an increase in volume ratio, 3.77 +/- 4.38% per 2714 micron2 area of tissue, in trypsin inhibitor-treated animals. All tissue components showed an increase in the experimental animals: acinar (125%), islet (144%), ductal (325%) and connective tissue (94%). Increased size of acinar cell nuclei, as measured by average cord length, 6.20 +/- 0.13 micron, and a decreased nuclear density of acinar cells, 28 +/- 4.74 per 150 micron2 area of tissue, indicated hypertrophic changes in these cells of the experimental animals. Using immunohistochemical localization and the point-count technique, a significant fraction of the total pancreatic volume in experimental animals was represented by ducts containing immunoreactive cells. The percent of volume ratio, 0.42 +/- 0.15% per 2714 micron2 area of tissue, was calculated for ducts containing insulin-immunoreactive cells within their epithelium.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3905472     DOI: 10.1007/bf00265028

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  22 in total

1.  Morphologic changes associated with sulfonylurea therapy.

Authors:  J M BLOODWORTH
Journal:  Metabolism       Date:  1963-04       Impact factor: 8.694

2.  Pancreatic adaptation to diabetogenic hormones.

Authors:  S S LAZARUS; B W VOLK
Journal:  AMA Arch Pathol       Date:  1959-04

3.  A histological study of the pancreas, liver and kidney both during and after recovery from alloxan diabetes.

Authors:  E L HOUSE
Journal:  Endocrinology       Date:  1958-02       Impact factor: 4.736

4.  Course of alloxan diabetes in duct-ligated rats. A functional and morphological study.

Authors:  C Edström
Journal:  Acta Pathol Microbiol Scand A       Date:  1973-01

5.  Neoformation of insulin-producing islets following ligation of the pancreatic ducts in normal and alloxan-diabetic rats.

Authors:  J Zweens; P R Bouman
Journal:  Acta Physiol Pharmacol Neerl       Date:  1967-12

6.  Histological changes in the pancreatic islets of alloxan-treated mice, with comments on beta-cell regeneration.

Authors:  G J Patent; M Alfert
Journal:  Acta Anat (Basel)       Date:  1967

7.  Pathologic anatomy of the pancreas in juvenile diabetes mellitus.

Authors:  W Gepts
Journal:  Diabetes       Date:  1965-10       Impact factor: 9.461

8.  Effect of tolbutamide on postnatal neogenesis of the islet of Langerhans in mouse.

Authors:  S C Bunnag; N E Warner; S Bunnag
Journal:  Diabetes       Date:  1966-08       Impact factor: 9.461

9.  Postnatal neogenesis of islets of langerhans in the mouse.

Authors:  S C Bunnag
Journal:  Diabetes       Date:  1966-07       Impact factor: 9.461

10.  Intermediate cells of the pancreas. II. The effects of dietary soybean trypsin inhibitor on acinar-beta cell structure and function in the rat.

Authors:  R N Melmed; R C Turner; S J Holt
Journal:  J Cell Sci       Date:  1973-07       Impact factor: 5.285

View more
  10 in total

Review 1.  Nesidioblastosis unravelled.

Authors:  R D Milner
Journal:  Arch Dis Child       Date:  1996-05       Impact factor: 3.791

2.  Organogenesis and differentiation of the pancreas in the toad Bufo bufo L.

Authors:  Solange Rouet-Karama; Jacques Albert
Journal:  Rouxs Arch Dev Biol       Date:  1988-05

Review 3.  Islet neogenesis: a possible pathway for beta-cell replenishment.

Authors:  Susan Bonner-Weir; Lili Guo; Wan-Chun Li; Limor Ouziel-Yahalom; Philippe A Lysy; Gordon C Weir; Arun Sharma
Journal:  Rev Diabet Stud       Date:  2012-12-28

4.  In vitro cytodifferentiation of perinatal rat islet cells within a tridimensional matrix of collagen.

Authors:  B Amory; J L Mourmeaux; C Remacle
Journal:  In Vitro Cell Dev Biol       Date:  1988-02

5.  What do we know about the effects of trypsin inhibitors on the pancreas?

Authors:  P M Pour
Journal:  Int J Pancreatol       Date:  1986-10

Review 6.  Centroacinar cells: At the center of pancreas regeneration.

Authors:  Rebecca L Beer; Michael J Parsons; Meritxell Rovira
Journal:  Dev Biol       Date:  2016-03-08       Impact factor: 3.582

7.  Enhanced expression of VEGF-A in β cells increases endothelial cell number but impairs islet morphogenesis and β cell proliferation.

Authors:  Qing Cai; Marcela Brissova; Rachel B Reinert; Fong Cheng Pan; Priyanka Brahmachary; Marie Jeansson; Alena Shostak; Aramandla Radhika; Greg Poffenberger; Susan E Quaggin; W Gray Jerome; Daniel J Dumont; Alvin C Powers
Journal:  Dev Biol       Date:  2012-04-24       Impact factor: 3.582

8.  Developmental pathways during in vitro progression of human islet neogenesis.

Authors:  Rikke Dodge; Cindy Loomans; Arun Sharma; Susan Bonner-Weir
Journal:  Differentiation       Date:  2008-11-06       Impact factor: 3.880

9.  Regulation of fluid secretion and intracellular messengers in isolated rat pancreatic ducts by acetylcholine.

Authors:  N Ashton; R L Evans; A C Elliott; R Green; B E Argent
Journal:  J Physiol       Date:  1993-11       Impact factor: 5.182

Review 10.  Beta-cell growth and regeneration: replication is only part of the story.

Authors:  Susan Bonner-Weir; Wan-Chun Li; Limor Ouziel-Yahalom; Lili Guo; Gordon C Weir; Arun Sharma
Journal:  Diabetes       Date:  2010-10       Impact factor: 9.461

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.